VIVITROL (naltrexone for extended-release injectable suspension) VIVITROL: A Treatment Option For The Daily Struggle Against Alcohol Dependence. One dose all month long.
Patient Site
Patient Information
Send to a Friend
Homepage About Vivitrol Links Contact Us SEARCH
About VIVITROL About VIVITROL
My Path to Recovery
What is VIVITROL?


How VIVITROL works


What to expect from treatment


The role of counseling


Is VIVITROL right for you?


Common Questions


Featured in this section: Locate a Physician

How VIVITROL works

VIVITROL works by binding to opioid receptors in the brain. Although the mechanism responsible for reduction in alcohol consumption is not entirely understood, preclinical data suggest that occupation of the opioid receptors by VIVITROL may result in the blockade of the neurotransmitters in the brain believed to be involved with alcohol dependence. This blockade may result in the reduction in alcohol consumption observed in patients treated with VIVITROL.7

VIVITROL is administered only once a month.  The medicine in VIVITROL is encased in microscopic biodegradable shells called microspheres.

VIVITROL is administered only once a month. The medicine in VIVITROL is encased in microscopic biodegradable shells called microspheres. Throughout the month, these shells slowly dissolve, releasing medicine every day.7

Important Safety Information
Naltrexone has the capacity to cause hepatocellular injury when given in excessive doses. Naltrexone is contraindicated in acute hepatitis or liver failure, and its use in patients with active liver disease must be carefully considered in light of its hepatotoxic effects. The margin of separation between the apparently safe dose of naltrexone and the dose causing hepatic injury appears to be only five-fold or less. VIVITROL does not appear to be a hepatotoxin at the recommended doses. Patients should be warned of the risk of hepatic injury and advised to seek medical attention if they experience symptoms of acute hepatitis. Use of VIVITROL should be discontinued in the event of symptoms and/or signs of acute hepatitis.
VIVITROL is indicated for the treatment of alcohol dependence in patients who are able to abstain from alcohol in an outpatient setting prior to initiation of treatment with VIVITROL.

Patients should not be actively drinking at the time of initial VIVITROL administration.

Treatment with VIVITROL should be part of a comprehensive management program that includes psychosocial support.